pc:recod

ReCode Therapeutics

Precision Medicine

ReCode Therapeutics is a clinical-stage genetic medicines company specializing in the precision delivery of mRNA and gene correction therapeutics. Utilizing its proprietary Selective Organ Targeting (SORT) lipid nanoparticle platform, ReCode aims to enhance the efficacy and potency of genetic medicines by targeting specific organs, tissues, and cells implicated in diseases. The company's lead programs focus on developing inhaled mRNA-based therapies for cystic fibrosis and primary ciliary dyskinesia, addressing genetic mutations that are unresponsive to existing treatments.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―

Estimated Valuation―

Total Amount Raised$29M

Total Amount Raised$29M

Total Funding Rounds1

Total Funding Rounds1

Latest Funding Amount$29M

Latest Funding Amount$29M

Latest Funding RoundInvestment

Latest Funding RoundInvestment

Post-Money Valuation―

Post-Money Valuation―

Funding Round

Sep 29, 2025

Investment

$29.00M

―

Investors

Cystic Fibrosis Foundation

Investment

Related News and Analysis

Thunes Wins Top Cross-Border Payments Award at MPE 2026, Underscoring Global Expansion Capabilities

Thunes Wins Top Cross-Border Payments Award at MPE 2026, Underscoring Global Expansion Capabilities

New updates have been reported about Thunes. Thunes has been named “Best Cross-Border Payment Solution” at the 2026...

12m ago

BotCity Expands Enterprise Sales Team Following $12M Series A Funding

BotCity Expands Enterprise Sales Team Following $12M Series A Funding

According to a recent LinkedIn post from BotCity, the company is recruiting for multiple enterprise sales roles focused...

23m ago

Netradyne Partnership Extension Targets Fleet Fuel and Operational Efficiency

Netradyne Partnership Extension Targets Fleet Fuel and Operational Efficiency

According to a recent LinkedIn post from Netradyne, the company is highlighting the next phase of its collaboration...

23m ago

Enterprise Adoption of Netradyne Safety Tech Highlighted Through Nestlé India Use Case

Enterprise Adoption of Netradyne Safety Tech Highlighted Through Nestlé India Use Case

According to a recent LinkedIn post from Netradyne, Nestlé India is highlighted as using the company’s driver safety...

23m ago

Slang AI Sponsors Hospitality Workforce Development Event in New York

Slang AI Sponsors Hospitality Workforce Development Event in New York

According to a recent LinkedIn post from Slang AI, the company participated as a sponsor in the NYC...

24m ago

Filevine Builds Legal Community Presence Around ABA TECHSHOW in Chicago

Filevine Builds Legal Community Presence Around ABA TECHSHOW in Chicago

According to a recent LinkedIn post from Filevine, the company recently hosted a community-focused event in Chicago ahead...

24m ago

TVM Capital Healthcare Highlights Emerging-Market Healthcare Investment Strategy

TVM Capital Healthcare Highlights Emerging-Market Healthcare Investment Strategy

According to a recent LinkedIn post from TVM Capital Healthcare, the firm is featured in a Global Private...

24m ago

Fractal Highlights Long-Term AI Conviction and Enterprise Adoption Focus

Fractal Highlights Long-Term AI Conviction and Enterprise Adoption Focus

According to a recent LinkedIn post from Fractal, the company drew attention to comments by executive Ajoy Singh...

24m ago

Storyblok Targets AI-Ready Content Management Demand Amid Scaling Challenges

Storyblok Targets AI-Ready Content Management Demand Amid Scaling Challenges

According to a recent LinkedIn post from Storyblok, the company is emphasizing that content teams are facing growing...

24m ago

Fractal Emphasizes Deep AI Specialization and Talent Development in India

Fractal Emphasizes Deep AI Specialization and Talent Development in India

According to a recent LinkedIn post from Fractal, the company is emphasizing artificial intelligence as an emerging scientific...

24m ago